Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 210

    AstraZeneca sells some rights to Nexium, Vimovo to Grunenthal

    AstraZeneca sells some rights to Nexium, Vimovo to Grunenthal

    Medical Dialogues Bureau31 Oct 2018 5:15 PM IST
    LONDON: AstraZeneca said it would sell the European rights to acid-reflux medicine Nexium to Grunenthal for an upfront $700 million and future...
    Monsanto India Q2 profit at Rs 24 cr, revenue up 33% at Rs 133.49 cr

    Monsanto India Q2 profit at Rs 24 cr, revenue up 33% at Rs 133.49 cr

    Medical Dialogues Bureau31 Oct 2018 5:14 PM IST
    New Delhi: Seed firm Monsanto India Monday reported a net profit of Rs 24.09 crore for the quarter ended September 2018. Its net loss stood at Rs 6.39...
    Granules gets 2 observation by USFDA for U.S Unit

    Granules gets 2 observation by USFDA for U.S Unit

    Medical Dialogues Bureau30 Oct 2018 10:48 AM IST
    New Delhi: Pharma firm Granules through a recent regulatory filing announced its US subsidiary has received two observations from the US health...
    Cipla gets USFDA approval for Metoprolol ER Tablets

    Cipla gets USFDA approval for Metoprolol ER Tablets

    Medical Dialogues Bureau30 Oct 2018 9:25 AM IST
    Mumbai: Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Metoprolol ER Tablets 50mg,...
    TherapeuticsMD gets FDA approval of Bijuva drug

    TherapeuticsMD gets FDA approval of Bijuva drug

    Medical Dialogues Bureau30 Oct 2018 9:20 AM IST
    New Delhi: TherapeuticsMD, Inc. an innovative women’s healthcare company, has recently announced that the United States Food and Drug Administration...
    Takeda proposes sale of Shire drug to gain European approval

    Takeda proposes sale of Shire drug to gain European approval

    Medical Dialogues Bureau30 Oct 2018 9:00 AM IST
    New Delhi: Takeda Pharmaceutical has proposed to European regulators it could sell a Shire treatment in development due to concerns of overlap in...
    Cipla gets USFDA approval for Hypertension, Cardiac drug

    Cipla gets USFDA approval for Hypertension, Cardiac drug

    Medical Dialogues Bureau29 Oct 2018 10:00 AM IST
    NEW DELHI: Pharmaceutical giant Cipla has recently announced that it has received final approval from the US health regulator to market Metoprolol...
    Big Pharma Companies to Return to Double-Digit Growth this Fiscal: Crisil

    Big Pharma Companies to Return to Double-Digit Growth this Fiscal: Crisil

    Medical Dialogues Bureau29 Oct 2018 9:45 AM IST
    Domestic revenues of big pharma companies are expected to grow 12-13 per cent this fiscal, given better access to healthcare and deeper penetration of...
    Novartis, Pfizer Team up to develop drugs for liver disease treatment

    Novartis, Pfizer Team up to develop drugs for liver disease treatment

    Medical Dialogues Bureau29 Oct 2018 9:30 AM IST
    ZURICH/NEW YORK: Novartis AG and Pfizer Inc are joining forces to develop treatments for a liver disease many drug companies believe will become a...
    Eye Disease Market Primed for Shake-up: Roche touts study data of experimental Antibody Faricimab

    Eye Disease Market Primed for Shake-up: Roche touts study data of experimental Antibody Faricimab

    Medical Dialogues Bureau29 Oct 2018 9:00 AM IST
    ZURICH: Swiss drugmaker Roche has touted data for a new drug against a blindness-causing eye disease that hits millions of older people, the latest...
    Delhi court issues notices to Sterling Biotech owners in Rs 8,100 crore bank loan fraud case

    Delhi court issues notices to Sterling Biotech owners in Rs 8,100 crore bank loan fraud case

    Medical Dialogues Bureau28 Oct 2018 10:54 AM IST
    New Delhi: A Delhi court has sought a response from Sterling Biotech promoters following an Enforcement Directorate's plea to declare them fugitive...
    Merck says to retain animal health business as part of company

    Merck says to retain animal health business as part of company

    Medical Dialogues Bureau28 Oct 2018 9:05 AM IST
    New Delhi: Merck & Co Inc has recently indicated that it would keep its animal health business as part of the company, in response to questions...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok